Article
Thalidomide embryopathy: Follow-up of cases born between 1959 and 2010.
Birth defects research. Part A, Clinical and molecular teratology - 1 Sept 2015
Kowalski Thayne Woycinck, Sanseverino Maria Teresa Vieira, Schuler-Faccini Lavinia, Vianna Fernanda Sales Luiz
Abstract excerpt
BACKGROUND: Thalidomide is a known teratogen and it is estimated that more than ten thousand babies were affected by thalidomide embryopathy (TE), which is characterized mainly by limb defects, but can involve many organs and systems. Most people with TE were only evaluated at birth and it is not well established if thalidomide exposure during embryonic development leads to later effects. We analyzed the clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.